Zomedica Corp. Share Price

ZOMDF

CA98980M1095

Healthcare Facilities & Services

Market Closed - OTC Markets Other stock markets 02:29:37 17/01/2026 am IST			5-day change	1st Jan Change
0.1314 ^USD	-10.46%		-8.68%	+29.17%

22/11	Zomedica Corp., Q3 2025 Earnings Call, Nov 21, 2025
22/11	Zomedica Seeks Acquisitions	CI

Last Transcript: Zomedica Corp.

Zomedica Corp., Q3 2025 Earnings Call, Nov 21, 2025

22/11

More transcripts

Analysts' recommendations: Zomedica Corp.

06/23/06	Dawson James Starts Zomedica Pharmaceuticals at Buy With $6 Price Target	MT
16/20/16	ZOMEDICA : HC Wainwright Adjusts Zomedica Pharmaceuticals' Price Target to $0.30 From $0.50, Keeps at Buy	MT

More recommendations

Press Releases: Zomedica Corp.

15/01	Zomedica Announces Fourth Friday at Four Webinar on January 23rd Focused on Digital Innovation and Technology-Driven Growth	AQ
04/12	Zomedica : Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay	PU
23/25/23	Zomedica : Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets	PU
05/25/05	Zomedica to Present at the OTCQB Venture Virtual Investor Conference August 7th	AQ
25/25/25	Zomedica Announces Issuance of Additional Patent for its TRUVIEW Microscope	AQ

More press releases

Managers and Directors: Zomedica Corp.

Manager	Title	Age	Since
Larry Heaton CEO	Chief Executive Officer	68	01/11/2021
Evan Saint Peter CTO	Chief Tech/Sci/R&D Officer	-	01/01/2018
Anthony Blair COO	Chief Operating Officer	64	01/01/2022

Director	Title	Age	Since
Rodney Williams BRD	Director/Board Member	64	27/04/2016
Jeffrey Rowe CHM	Chairman	69	02/12/2019
Johnny Powers BRD	Director/Board Member	63	16/08/2019

More insiders

Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.

Employees

152

Sector

Healthcare Facilities & Services

Calendar

04/03 - Q4 2025 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
16/26/16	0.1314 $	-10.46%	34,98,455
15/26/15	0.1468 $	-4.80%	13,75,516
14/26/14	0.1542 $	+0.13%	17,24,340
13/26/13	0.1540 $	+0.65%	25,81,158
12/26/12	0.1530 $	+6.25%	33,13,940

Delayed Quote OTC Markets, January 17, 2026 at 02:29 am IST

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Capitalization	9.97Cr 8.6Cr 8Cr 7.45Cr 14Cr 904.7Cr 15Cr 92Cr 36Cr 431.54Cr 37Cr 37Cr 1.58TCr	P/E ratio 2023	-5.68x	P/E ratio 2024	-2.5x
Enterprise value	3.02Cr 2.6Cr 2.42Cr 2.25Cr 4.2Cr 273.75Cr 4.52Cr 28Cr 11Cr 130.58Cr 11Cr 11Cr 476.8Cr	EV / Sales 2023	43,04,730x	EV / Sales 2024	17,61,223x
Free-Float	98.13%	Yield 2023 *	-	Yield 2024	-

22/11	Zomedica Corp., Q3 2025 Earnings Call, Nov 21, 2025
22/11	Zomedica Seeks Acquisitions	CI
05/11	Zomedica Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
07/25/07	Zomedica Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
28/25/28	Zomedica Corp. - Special Call
25/25/25	Zomedica Announces Issuance of Additional Patent for its TRUVIEW Microscope	CI
30/25/30	Zomedica Corp. - Special Call
16/25/16	Zomedica Corp., Q1 2025 Earnings Call, May 15, 2025
16/25/16	Zomedica Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
30/25/30	Zomedica Inc. and Zomedica Corp. Announces Resignation of Scott Jordan as Chief Financial Officer, Effective April 25, 2025	CI
14/25/14	Zomedica Corp., Q4 2024 Earnings Call, Mar 13, 2025
14/25/14	Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
10/25/10	Zomedica Corp.(OTCPK:ZOMD.F) dropped from S&P Global BMI Index	CI

1 day	-10.46%
1 week	-8.68%
Current month	+29.17%
1 month	+18.47%
3 months	+110.40%
6 months	+260.27%
Current year	+29.17%

1 week	0.1	0.16
1 month	0.09	0.16
Current year	0.1	0.16
1 year	0.02	0.16
3 years	0.02	0.3
5 years	0.02	2.91
10 years	0.02	2.98

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ZOMEDICA CORP.	-10.46%	-8.68%	+1.39%	-50.84%	13Cr
CVS GROUP PLC	0.00%	+1.78%	+48.75%	-28.53%	129.68Cr
APIAM ANIMAL HEALTH LIMITED	0.00%	-0.57%	+105.95%	+41.80%	11Cr
JAPAN ANIMAL REFERRAL MEDICAL CENTER CO., LTD.	+1.03%	+3.25%	+177.29%	+242.87%	10Cr
WOLVES HAND CO., LTD.	+2.10%	+2.97%	+145.39%	-	9Cr
Average	-1.47%	-1.60%	+95.75%	+51.33%	34.51Cr
Weighted average by Cap.	-0.61%	+0.32%	+61.46%	-8.63%

Zomedica Corp. Share Price

Equities

ZOMDF

CA98980M1095

Healthcare Facilities & Services

Valuation: Zomedica Corp.

Chart: Zomedica Corp.

Latest news: Zomedica Corp.

Last Transcript: Zomedica Corp.

Analysts' recommendations: Zomedica Corp.

Press Releases: Zomedica Corp.

Quotes and Performance

Course Extremes

Managers and Directors: Zomedica Corp.

ETFs: Zomedica Corp.

Veterinary Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

	2023	2024
Net sales	25.19 21.71 20.21 18.82 35.04 2.29T 37.7 232.51 91.68 1.09T 94.45 92.51 3.98T	27.28 23.52 21.9 20.39 37.96 2.48T 40.84 251.88 99.32 1.18T 102.32 100.22 4.31T
Net income	-3.45Cr -2.98Cr -2.77Cr -2.58Cr -4.8Cr -313.29Cr -5.17Cr -32Cr -13Cr -149.44Cr -13Cr -13Cr -545.68Cr	-4.7Cr -4.05Cr -3.77Cr -3.51Cr -6.54Cr -426.28Cr -7.03Cr -43Cr -17Cr -203.34Cr -18Cr -17Cr -742.48Cr
Net Debt	-8.78Cr -7.57Cr -7.04Cr -6.56Cr -12Cr -796.34Cr -13Cr -81Cr -32Cr -379.85Cr -33Cr -32Cr -1.39TCr	-6.95Cr -5.99Cr -5.58Cr -5.2Cr -9.67Cr -630.95Cr -10Cr -64Cr -25Cr -300.96Cr -26Cr -26Cr -1.1TCr